ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
-0.04%
Brent Oil
82.765
-1.03%
Bitcoin
62,829.56
6.27%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) News

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PLX
DateTimeSourceHeadlineSymbolCompany
02/01/202411:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
26/12/202311:56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
30/11/202309:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
06/11/202312:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
06/11/202312:22Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
31/10/202320:40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
20/10/202311:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
03/10/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
03/10/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
03/10/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
03/10/202322:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
15/09/202321:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
15/09/202321:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
12/09/202311:58Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
06/09/202311:50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
17/08/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
17/08/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
17/08/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
17/08/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
11/08/202321:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
07/08/202312:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
07/08/202311:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
13/07/202321:41Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
07/07/202321:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
29/06/202312:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
29/06/202312:24Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
28/06/202321:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202321:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
30/05/202312:24Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
18/05/202322:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:PLX

Your Recent History

LSE
TERN
Tern
LSE
AGL
Angle
LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
AAZ
Anglo Asian Mining
LSE
SCE
Surface Transforms
LSE
PHNX
Phoenix
LSE
BT.A
Bt
LSE
SCLP
Scancell
LSE
AAU
Ariana Resources
LSE
GOLD
LSE
IES
Invinity Energy Systems
LSE
VAST
Vast Resources
LSE
DELT
Deltic Energy
LSE
ZPHR
Zephyr Energy
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved